Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$22.21 - $34.48 $64,342 - $99,888
2,897 Added 3.65%
82,287 $2.67 Million
Q1 2024

May 03, 2024

BUY
$21.1 - $27.46 $30,278 - $39,405
1,435 Added 1.84%
79,390 $2 Million
Q4 2023

Feb 08, 2024

BUY
$24.82 - $32.88 $32,613 - $43,204
1,314 Added 1.71%
77,955 $2.53 Million
Q3 2023

Nov 09, 2023

SELL
$21.97 - $33.8 $65,009 - $100,014
-2,959 Reduced 3.72%
76,641 $2.09 Million
Q2 2023

Aug 07, 2023

SELL
$21.44 - $25.15 $135,522 - $158,973
-6,321 Reduced 7.36%
79,600 $1.77 Million
Q1 2023

May 01, 2023

BUY
$19.2 - $24.47 $412,992 - $526,349
21,510 Added 33.39%
85,921 $1.86 Million
Q4 2022

Feb 07, 2023

SELL
$19.95 - $29.96 $82,672 - $124,154
-4,144 Reduced 6.04%
64,411 $1.31 Million
Q3 2022

Oct 25, 2022

SELL
$24.7 - $29.12 $13,856 - $16,336
-561 Reduced 0.81%
68,555 $1.76 Million
Q2 2022

Aug 08, 2022

BUY
$17.33 - $25.3 $26,410 - $38,557
1,524 Added 2.25%
69,116 $1.64 Million
Q1 2022

May 06, 2022

SELL
$16.53 - $25.21 $13,273 - $20,243
-803 Reduced 1.17%
67,592 $1.52 Million
Q4 2021

Feb 08, 2022

SELL
$17.1 - $23.34 $150,223 - $205,041
-8,785 Reduced 11.38%
68,395 $1.35 Million
Q3 2021

Oct 28, 2021

SELL
$19.68 - $22.53 $20,565 - $23,543
-1,045 Reduced 1.34%
77,180 $1.52 Million
Q2 2021

Jul 27, 2021

SELL
$19.97 - $24.43 $13,060 - $15,977
-654 Reduced 0.83%
78,225 $1.72 Million
Q1 2021

May 03, 2021

SELL
$23.49 - $30.56 $119,188 - $155,061
-5,074 Reduced 6.04%
78,879 $1.88 Million
Q4 2020

Feb 04, 2021

SELL
$16.78 - $27.3 $221,630 - $360,578
-13,208 Reduced 13.59%
83,953 $2.2 Million
Q3 2020

Nov 06, 2020

BUY
$12.46 - $19.98 $195,248 - $313,086
15,670 Added 19.23%
97,161 $1.69 Million
Q2 2020

Aug 04, 2020

SELL
$11.0 - $18.26 $67,254 - $111,641
-6,114 Reduced 6.98%
81,491 $1.37 Million
Q1 2020

Apr 27, 2020

BUY
$10.11 - $14.04 $174,427 - $242,232
17,253 Added 24.52%
87,605 $1.04 Million
Q4 2019

Feb 03, 2020

BUY
$12.06 - $16.96 $8,550 - $12,024
709 Added 1.02%
70,352 $851,000
Q3 2019

Oct 31, 2019

SELL
$10.41 - $14.66 $13,460 - $18,955
-1,293 Reduced 1.82%
69,643 $984,000
Q2 2019

Aug 09, 2019

BUY
$9.78 - $12.76 $498 - $650
51 Added 0.07%
70,936 $791,000
Q1 2019

May 02, 2019

BUY
$10.03 - $15.71 $21,283 - $33,336
2,122 Added 3.09%
70,885 $832,000
Q4 2018

Feb 11, 2019

BUY
$11.29 - $17.19 $26,136 - $39,794
2,315 Added 3.48%
68,763 $919,000
Q3 2018

Oct 22, 2018

BUY
$12.27 - $15.65 $57,889 - $73,836
4,718 Added 7.64%
66,448 $932,000
Q2 2018

Jul 23, 2018

SELL
$15.3 - $19.69 $20,884 - $26,876
-1,365 Reduced 2.16%
61,730 $970,000
Q1 2018

Apr 20, 2018

BUY
$14.59 - $25.5 $308,826 - $539,758
21,167 Added 50.48%
63,095 $1.04 Million
Q4 2017

Jan 23, 2018

BUY
$15.77 - $20.72 $661,204 - $868,748
41,928
41,928 $757,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.82B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.